Current Cancer Drug Targets

Editor-in-Chief

Ruiwen Zhang
Center for Drug Discovery
University of Houston
3455 Cullen Blvd.
Houston, TX 77204
(USA)

Personal Subscription
Become EABM
Become Reviewer
Call for Editor
Volume: 4 Issue: 4, June

Novel Approaches for Targeted Cancer Therapy

Volume:4   Issue: 4
Pp: 313-326
Veronique Guillemard and H. Uri Saragovi
DOI: 10.2174/1568009043332989
Published on: 01 March, 2012

Signaling Pathways Responsible for Cancer Cell Invasion as Targets for Cancer Therapy

Volume:4   Issue: 4
Pp: 327-336
Daniel Sliva
DOI: 10.2174/1568009043332961
Published on: 01 March, 2012

Microfilament Actin Remodeling as a Potential Target for Cancer Drug Development

Volume:4   Issue: 4
Pp: 345-354
Jian Yu Rao and Ning Li
DOI: 10.2174/1568009043332998
Published on: 01 March, 2012

Vitamin E Analogues: A New Class of Inducers of Apoptosis with Selective Anti-Cancer Effects

Volume:4   Issue: 4
Pp: 355-372
Jiri Neuzil, Marco Tomasetti, Albert S. Mellick, Renata Alleva, Brian A. Salvatore, Marc Birringer and Marc W. Fariss
DOI: 10.2174/1568009043332943
Published on: 01 March, 2012

Potent Chemopreventive Agents Against Pancreatic Cancer

Volume:4   Issue: 4
Pp: 373-384
Akiyoshi Nishikawa, Fumio Furukawa, In-Seon Lee, Takuji Tanaka and Masao Hirose
DOI: 10.2174/1568009043332970
Published on: 01 March, 2012